Dynamics of Antibiotic Resistance of Streptococcus pneumoniae in France: A Pediatric Prospective Nasopharyngeal Carriage Study from 2001 to 2022.

Details

Ressource 1Request a copy Under indefinite embargo.
UNIL restricted access
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_6A7A08C2BCF7
Type
Article: article from journal or magazin.
Collection
Publications
Title
Dynamics of Antibiotic Resistance of Streptococcus pneumoniae in France: A Pediatric Prospective Nasopharyngeal Carriage Study from 2001 to 2022.
Journal
Antibiotics
Author(s)
Rybak A., Levy C., Ouldali N., Bonacorsi S., Béchet S., Delobbe J.F., Batard C., Donikian I., Goldrey M., Assouline J., Cohen R., Varon E.
ISSN
2079-6382 (Print)
ISSN-L
2079-6382
Publication state
Published
Issued date
06/06/2023
Peer-reviewed
Oui
Volume
12
Number
6
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Abstract
Epidemiological surveillance of nasopharyngeal pneumococcal carriage is important for monitoring serotype distribution and antibiotic resistance, particularly before and after the implementation of pneumococcal conjugate vaccines (PCVs). With a prospective surveillance study in France, we aimed to analyze the dynamics of pneumococcal carriage, antibiotic susceptibility and serotype distribution in children aged 6 to 24 months who had acute otitis media between 2001 and 2022 with a focus on the late PCV13 period from May 2014 to July 2022. Trends were analyzed with segmented linear regression with autoregressive error. For the 17,136 children enrolled, overall pneumococcal carriage was stable during the study. During the late PCV13 period, the five most frequent serotypes were all non-PCV13 serotypes: 15B/C (14.3%), 23B (11.0%), 11A (9.6%), 15A (7.4%) and 35B (6.5%). During the same period, we observed a rebound of penicillin non-susceptibility (+0.15% per month, 95% confidence interval, +0.08 to 0.22, p < 0.001). Five serotypes accounted for 64.4% of the penicillin non-susceptible strains: 11A (17.5%), 35B (14.9%), 15A (13.9%), 15B/C (9.9%) and 19F (8.2%); non-PCV13/PCV15 accounted for <1%, and non-PCV15/PCV20 accounted for 28%. The next generation PCVs, particularly PCV20, may disrupt nasopharyngeal carriage and contribute to decreasing the rate of antibiotic resistance among pneumococci.
Keywords
PCV impact, acute otitis media, children, next-generation pneumococcal conjugate vaccine, pneumococcal nasopharyngeal carriage, third-generation pneumococcal conjugate vaccine
Pubmed
Web of science
Open Access
Yes
Create date
27/01/2025 15:15
Last modification date
28/01/2025 8:07
Usage data